Impact of interventional and non‐interventional variables on anthropometric long‐term development in glutaric aciduria type 1: A national prospective multi‐centre study

Autor: Chris Mühlhausen, Katharina Mengler, Eva Thimm, Martin Lindner, Stefan Kölker, Anibh M. Das, Regina Ensenauer, E. M. Charlotte Märtner, Esther M. Maier, Jana Heringer-Seifert, Dominic Lenz, Matthias R. Baumgartner, Judith Vossbeck, Peter Freisinger, Sven F. Garbade, Skadi Beblo, Katharina A. Schiergens, Robert Steinfeld, Sarah C. Grünert, Iris Marquardt, Natalie Weinhold, René Santer, Andrea Dieckmann, Georg F. Hoffmann, Andrea Näke, Nikolas Boy, Thorsten Marquardt
Přispěvatelé: University of Zurich, Boy, Nikolas
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Pediatrics
Glutaric aciduria type 1
Body Mass Index
Germany
Prospective Studies
Child
Genetics (clinical)
2. Zero hunger
Dystonia
0303 health sciences
Anthropometry
Glutaryl-CoA Dehydrogenase
Brain Diseases
Metabolic

030305 genetics & heredity
3. Good health
Child
Preschool

Female
medicine.symptom
medicine.medical_specialty
2716 Genetics (clinical)
Adolescent
610 Medicine & health
Young Adult
03 medical and health sciences
Neonatal Screening
Sex Factors
1311 Genetics
Genetics
medicine
Humans
Amino Acid Metabolism
Inborn Errors

Emergency Treatment
030304 developmental biology
Newborn screening
business.industry
Body Weight
Infant
Newborn

Macrocephaly
Infant
medicine.disease
Body Height
Megalencephaly
10036 Medical Clinic
Observational study
business
Body mass index
Glutaric Acidemia Type 1
Popis: Glutaric aciduria type 1 (GA1) is a rare neurometabolic disorder, caused by inherited deficiency of glutaryl-CoA dehydrogenase, mostly affecting the brain. Early identification by newborn screening (NBS) significantly improves neurologic outcome. It has remained unclear whether recommended therapy, particular low lysine diet, is safe or negatively affects anthropometric long-term outcome. This national prospective, observational, multi-centre study included 79 patients identified by NBS and investigated effects of interventional and non-interventional parameters on body weight, body length, body mass index (BMI) and head circumference as well as neurological parameters. Adherence to recommended maintenance and emergency treatment (ET) had a positive impact on neurologic outcome and allowed normal anthropometric development until adulthood. In contrast, non-adherence to ET, resulting in increased risk of dystonia, had a negative impact on body weight (mean SDS -1.07; P = .023) and body length (mean SDS -1.34; P = -.016). Consistently, longitudinal analysis showed a negative influence of severe dystonia on weight and length development over time (P < .001). Macrocephaly was more often found in female (mean SDS 0.56) than in male patients (mean SDS -0.20; P = .049), and also in individuals with high excreter phenotype (mean SDS 0.44) compared to low excreter patients (mean SDS -0.68; P = .016). In GA1, recommended long-term treatment is effective and allows for normal anthropometric long-term development up to adolescence, with gender- and excreter type-specific variations. Delayed ET and severe movement disorder result in poor anthropometric outcome.
Databáze: OpenAIRE